by Miguel-Angel Perales
Miguel-Angel Perales, MD, FASTCT, is the senior author of “ASTCT Consensus Grading for Immune Effector Cell-Associated Toxicities 2026 Update.” In this Q&A, he discusses the...
by ASTCT Talks
In this episode of ASTCT Talks, host Daniel Olson, MD, medical oncologist and co-leader of the melanoma, sarcoma, and solid tumor cellular therapy programs at the University of Chicago, is joined...
by Alex Kadhim
Two decades of follow-up analysis performed by the Department of Hematology at Leiden University Medical Center, with collaboration from HagaZiekenhuis in The Hague and Medisch Spectrum Twente in...
by Alex Kadhim
Regulatory T cells (Tregs) sourced from unrelated, human leukocyte antigen (HLA)-unmatched donors and activated overnight are able to be infused safely following transplant, according to a phase...
by Alex Kadhim
Analysis drawing on tumor-infiltrating lymphocyte (TIL) therapy performed at Memorial Sloan Kettering Cancer Center in New York, with collaboration at Weill Cornell Medical College and Stanford...
by Alex Kadhim
A case report from the University of Kansas Medical Center highlights how a documented drug intolerance mislabeled as an allergy can leave a profoundly immunosuppressed cancer patient without...